EUVIMEDEUVIMED entdecken
Crossref

Phenotypic effect of the mutations H78Y and L83V in the E6 protein of human papillomavirus

N Di Domizio, A Debernardi, M Olivier, E Bôle-Richard, B Caël, S Gaillot, J-L Prétet, Q Lepiller

Archives of Virology · 2026

DOI: 10.1007/s00705-025-06490-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Virology, 2026. Verfasst von N Di Domizio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Marie et Louis Pasteur, CNRS, Chrono-environnement, Besançon, F-25000, France. Hauptthemen laut MEDLINE: Oncogene Proteins, Viral, Repressor Proteins, Human papillomavirus 16, Papillomavirus Infections. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Conseil Régional de Franche-Comté.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV) 16 variants can differ in their oncogenic potential. Here, we investigated the effect of the amino acid substitutions H78Y and L83V in the E6 oncoprotein of HPV16 on early immune escape and p53 degradation in vitro. Although E6 inhibits the RIG-I-IRF-3-IFN-β pathway, this inhibition was not affected by the H78Y substitution. We found that the L83V mutation did not significantly affect p53 and p21 expression, cell migration and proliferation, or resistance to apoptosis. We therefore conclude that the H78Y and L83V substitutions in E6 had no phenotypic effect on early immune escape and p53 degradation, respectively, in our model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncogene Proteins, ViralRepressor ProteinsHuman papillomavirus 16Papillomavirus InfectionsHumansAmino Acid SubstitutionTumor Suppressor Protein p53MutationCell ProliferationApoptosisPhenotypeCell MovementImmune EvasionCyclin-Dependent Kinase Inhibitor p21Human Papillomavirus Viruses

Stichwörter der Autor:innen

CarcinogenesisE6 oncoproteinHPV16Immune escape

Substanzen

Oncogene Proteins, ViralE6 protein, Human papillomavirus type 16Repressor ProteinsTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p21

Autor:innen und Institutionen

  • Université Marie et Louis Pasteur, CNRS, Chrono-environnement, Besançon, F-25000, France.
  • CHU Besançon, Centre National de Référence Papillomavirus, Besançon, F-25000, France.
  • FC Innov', F-25000, Bionovéo, Besançon, France.
  • Université Marie et Louis Pasteur, INSERM, UMR1098, Besançon, F-25000, France.
  • Laboratoire de biologie cellulaire et moléculaire, CHU Besançon, France.
  • Université Marie et Louis Pasteur, CNRS, Chrono-environnement, Besançon, F-25000, France. q1lepiller@chu-besancon.fr.

Förderung

  • Conseil Régional de Franche-Comté

Zitieren

APA

Di Domizio, N., Debernardi, A., Olivier, M., Bôle-Richard, E., Caël, B., Gaillot, S., Prétet, J. L., & Lepiller, Q. (2026). Phenotypic effect of the mutations H78Y and L83V in the E6 protein of human papillomavirus. Archives of Virology. https://doi.org/10.1007/s00705-025-06490-4

Vancouver

Di Domizio N, Debernardi A, Olivier M, Bôle-Richard E, Caël B, Gaillot S, et al. Phenotypic effect of the mutations H78Y and L83V in the E6 protein of human papillomavirus. Archives of Virology. 2026. doi:10.1007/s00705-025-06490-4

BibTeX
@article{DiDomizio2026,
  author = {Di Domizio, N and Debernardi, A and Olivier, M and Bôle-Richard, E and Caël, B and Gaillot, S and Prétet, J-L and Lepiller, Q},
  title = {Phenotypic effect of the mutations H78Y and L83V in the E6 protein of human papillomavirus},
  journal = {Archives of Virology},
  year = {2026},
  doi = {10.1007/s00705-025-06490-4}
}
Kostenlos starten →